Long term visual outcomes in ranibizumab non-responders: patients with neovascular age-related macular degeneration switched from ranibizumab to aflibercept

被引：0
|
作者：
Afshar, Farid [1 ]
Fletcher, Emily [1 ]
Mohamed, Quresh [1 ]
Johnston, Rob [1 ]
机构：
[1] Cheltenham Gen Hosp, Ophthalmol, Eastleigh, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
520
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials
    Waldstein, Sebastian M.
    Simader, Christian
    Staurenghi, Giovanni
    Chong, N. Victor
    Mitchell, Paul
    Jaffe, Glenn J.
    Lu, Chengxing
    Katz, Todd A.
    Schmidt-Erfurth, Ursula
    OPHTHALMOLOGY, 2016, 123 (07) : 1521 - 1529
  • [32] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [33] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Heussen, Florian M.
    Shao, Qing
    Ouyang, Yanling
    Joussen, Antonia M.
    Mueller, Bert
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 909 - 915
  • [34] Clinical outcome of switching from ranibizumab to aflibercept in the treatment of neovascular age-related macular degeneration
    Lu, Lin
    Muthulingam, Gnanaruban
    Osborne, Claire
    Tonne, Prabhu
    Reddy, Gopinath
    Logendran, Maharatnam
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [35] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Marquis, Liza-Marie
    Mantel, Irmela
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1591 - 1596
  • [36] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Liza-Marie Marquis
    Irmela Mantel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1591 - 1596
  • [37] Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
    Cohen, Salomon Yves
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    OPHTHALMOLOGICA, 2014, 231 (02) : 80 - 85
  • [38] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [39] Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply
    Silva, Rufino
    Axer-Siegel, Ruth
    Eldem, Bora
    Guymer, Robyn
    Kirchhof, Bernd
    Papp, Andras
    Seres, Andras
    Gekkieva, Margarita
    Nieweg, Annette
    Pilz, Stefan
    OPHTHALMOLOGY, 2013, 120 (09) : E69 - E69
  • [40] LONG-TERM EFFICACY OF RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Chew, Jamie
    Syed, Adil
    Joachim, Nichole
    Li, Haitao
    Broadhead, Geoffrey K.
    Zhu, Meidong
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 98 - 98
12345